Xiaobo Mao, Ph.D
Affiliations: | 2010- | Johns Hopkins University School of Medicine, Baltimore, MD, United States |
Area:
Neurodegeneration, alpha-synuclein, amyloidWebsite:
http://www.hopkinsmedicine.org/profiles/results/directory/profile/10003736/xiaobo-maoGoogle:
"Xiaobo Mao"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Ted M. Dawson | post-doc | 2010-2016 | Johns Hopkins Medical School |
| Valina L. Dawson | post-doc | 2010-2016 | Johns Hopkins Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen C, Kumbhar R, Wang H, et al. (2024) Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron Transmission. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2303775 |
| Shastry S, Hu J, Ying M, et al. (2023) Cell Therapy for Parkinson's Disease. Pharmaceutics. 15 |
| Wang H, Yin X, Xu J, et al. (2023) Interspecies chimerism with human embryonic stem cells generates functional human dopamine neurons at low efficiency. Stem Cell Reports |
| Kang H, Park S, Jo A, et al. (2023) PARIS undergoes liquid-liquid phase separation and poly(ADP-ribose)-mediated solidification. Embo Reports. e56166 |
| Chen C, Kumbhar R, Wang H, et al. (2023) Pathological Tau transmission initiated by binding lymphocyte-activation gene 3. Biorxiv : the Preprint Server For Biology |
| Deyell JS, Sriparna M, Ying M, et al. (2023) The Interplay between α-Synuclein and Microglia in α-Synucleinopathies. International Journal of Molecular Sciences. 24 |
| Butler YR, Liu Y, Kumbhar R, et al. (2022) α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice. Nature Communications. 13: 4060 |
| Panicker N, Kam TI, Wang H, et al. (2022) Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease. Neuron |
| Seo BA, Kim D, Hwang H, et al. (2021) TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease. Neuron |
| Jo A, Lee Y, Kam TI, et al. (2021) PARIS farnesylation prevents neurodegeneration in models of Parkinson's disease. Science Translational Medicine. 13 |